200 related articles for article (PubMed ID: 38489355)
1. Redirecting raltitrexed from cancer cell thymidylate synthase to
Singh A; Ottavi S; Krieger I; Planck K; Perkowski A; Kaneko T; Davis AM; Suh C; Zhang D; Goullieux L; Alex A; Roubert C; Gardner M; Preston M; Smith DM; Ling Y; Roberts J; Cautain B; Upton A; Cooper CB; Serbina N; Tanvir Z; Mosior J; Ouerfelli O; Yang G; Gold BS; Rhee KY; Sacchettini JC; Fotouhi N; Aubé J; Nathan C
Sci Adv; 2024 Mar; 10(11):eadj6406. PubMed ID: 38489355
[TBL] [Abstract][Full Text] [Related]
2. AcpM, the meromycolate extension acyl carrier protein of Mycobacterium tuberculosis, is activated by the 4'-phosphopantetheinyl transferase PptT, a potential target of the multistep mycolic acid biosynthesis.
Zimhony O; Schwarz A; Raitses-Gurevich M; Peleg Y; Dym O; Albeck S; Burstein Y; Shakked Z
Biochemistry; 2015 Apr; 54(14):2360-71. PubMed ID: 25785780
[TBL] [Abstract][Full Text] [Related]
3. 4'-Phosphopantetheinyl transferase PptT, a new drug target required for Mycobacterium tuberculosis growth and persistence in vivo.
Leblanc C; Prudhomme T; Tabouret G; Ray A; Burbaud S; Cabantous S; Mourey L; Guilhot C; Chalut C
PLoS Pathog; 2012 Dec; 8(12):e1003097. PubMed ID: 23308068
[TBL] [Abstract][Full Text] [Related]
4. Detection of soluble co-factor dependent protein expression in vivo: application to the 4'-phosphopantetheinyl transferase PptT from Mycobacterium tuberculosis.
Rottier K; Faille A; Prudhomme T; Leblanc C; Chalut C; Cabantous S; Guilhot C; Mourey L; Pedelacq JD
J Struct Biol; 2013 Sep; 183(3):320-328. PubMed ID: 23916562
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into phosphopantetheinyl hydrolase PptH from Mycobacterium tuberculosis.
Mosior J; Bourland R; Soma S; Nathan C; Sacchettini J
Protein Sci; 2020 Mar; 29(3):744-757. PubMed ID: 31886928
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the essential Mycobacterium tuberculosis phosphopantetheinyl transferase PptT, solved as a fusion protein with maltose binding protein.
Jung J; Bashiri G; Johnston JM; Brown AS; Ackerley DF; Baker EN
J Struct Biol; 2014 Dec; 188(3):274-8. PubMed ID: 25450595
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking to Toxoplasma gondii thymidylate synthase-dihydrofolate reductase and efficacy of raltitrexed in infected mice.
de Paula Reis M; de Lima DA; Pauli KB; Andreotti CEL; de Moraes ALS; Gonçalves DD; Navarro IT; Bueno PSA; Seixas FAV; Gasparotto Junior A; Lourenço ELB
Parasitol Res; 2018 May; 117(5):1465-1471. PubMed ID: 29550996
[TBL] [Abstract][Full Text] [Related]
8. Opposing reactions in coenzyme A metabolism sensitize
Ballinger E; Mosior J; Hartman T; Burns-Huang K; Gold B; Morris R; Goullieux L; Blanc I; Vaubourgeix J; Lagrange S; Fraisse L; Sans S; Couturier C; Bacqué E; Rhee K; Scarry SM; Aubé J; Yang G; Ouerfelli O; Schnappinger D; Ioerger TR; Engelhart CA; McConnell JA; McAulay K; Fay A; Roubert C; Sacchettini J; Nathan C
Science; 2019 Feb; 363(6426):. PubMed ID: 30705156
[No Abstract] [Full Text] [Related]
9. In Vitro and In Vivo Inhibition of the
Ottavi S; Scarry SM; Mosior J; Ling Y; Roberts J; Singh A; Zhang D; Goullieux L; Roubert C; Bacqué E; Lagiakos HR; Vendome J; Moraca F; Li K; Perkowski AJ; Ramesh R; Bowler MM; Tracy W; Feher VA; Sacchettini JC; Gold BS; Nathan CF; Aubé J
J Med Chem; 2022 Feb; 65(3):1996-2022. PubMed ID: 35044775
[TBL] [Abstract][Full Text] [Related]
10. Preclinical cellular pharmacology of LY231514 (MTA): a comparison with methotrexate, LY309887 and raltitrexed for their effects on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.
Chen VJ; Bewley JR; Andis SL; Schultz RM; Iversen PW; Shih C; Mendelsohn LG; Seitz DE; Tonkinson JL
Br J Cancer; 1998; 78 Suppl 3(Suppl 3):27-34. PubMed ID: 9717988
[TBL] [Abstract][Full Text] [Related]
11. Raltitrexed in mesothelioma.
Surmont VF; van Meerbeeck JP
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1481-90. PubMed ID: 21999120
[TBL] [Abstract][Full Text] [Related]
12. A rationale for the clinical development of the thymidylate synthase inhibitor ZD9331 in ovarian and other solid tumours.
Jackman AL; Melin CJ; Kimbell R; Brunton L; Aherne GW; Theti DS; Walton M
Biochim Biophys Acta; 2002 Jul; 1587(2-3):215-23. PubMed ID: 12084463
[TBL] [Abstract][Full Text] [Related]
13. Raltitrexed induces mitochondrial‑mediated apoptosis in SGC7901 human gastric cancer cells.
Xue S; Chen YX; Qin SK; Yang AZ; Wang L; Xu HJ; Geng HY
Mol Med Rep; 2014 Oct; 10(4):1927-34. PubMed ID: 25109431
[TBL] [Abstract][Full Text] [Related]
14. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
[TBL] [Abstract][Full Text] [Related]
15. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of the acyl carrier protein synthase (AcpS) from Mycobacterium tuberculosis.
Dym O; Albeck S; Peleg Y; Schwarz A; Shakked Z; Burstein Y; Zimhony O
J Mol Biol; 2009 Nov; 393(4):937-50. PubMed ID: 19733180
[TBL] [Abstract][Full Text] [Related]
17. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
[No Abstract] [Full Text] [Related]
18. Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: is this drug active against acute myelogenous leukemia?
Takemura Y; Kobayashi H; Miyachi H
Int J Hematol; 2000 Jul; 72(1):112-4. PubMed ID: 10979221
[No Abstract] [Full Text] [Related]
19. Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
Guo B; Cao S; Tóth K; Azrak RG; Rustum YM
Clin Cancer Res; 2000 Feb; 6(2):718-24. PubMed ID: 10690558
[TBL] [Abstract][Full Text] [Related]
20. The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model.
Widemann BC; Balis FM; Godwin KS; McCully C; Adamson PC
Cancer Chemother Pharmacol; 1999; 44(6):439-43. PubMed ID: 10550563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
